- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04173416
The Youth Opioid Recovery Support (YORS) Intervention (YORS)
The Youth Opioid Recovery Support (YORS) Intervention: An Assertive Community Treatment Model for Improving Medication Adherence in Young Adults With Opioid Use Disorder
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Young people are disproportionately affected by the current opioid crisis including worse retention and outcomes compared to older adults. Further, young adults typically do not have access to medications for opioid use disorder (OUD), and for those that do, struggles with adherence are a major barrier. Standard approaches to treatment typically do not incorporate developmentally informed strategies for engagement, retention, and medication adherence for this special population.
The Youth Opioid Recovery Support (YORS) model is an innovative wrap-around approach that attempts to address barriers to treatment engagement in this vulnerable young adult population, especially difficulties with medication adherence. Its components include: (1) Home delivery of extended release naltrexone (XR-NTX) for OUD; (2) Engagement of families in collaborative treatment planning and monitoring focusing on medication adherence; (3) Assertive outreach from the treatment team including actively tracking and communicating with youth and families by text messaging and social media to promote engagement and adherence; and (4) Contingency management to provide incentives for medication adherence. YORS is currently showing very promising results in a small pilot randomized clinical trial (RCT) by the investigative team.
The investigators propose to refine and then conduct a more definitive test of the YORS intervention for youth with OUD. In the first phase the investigators will conduct stakeholder focus groups to get input and feedback on potential refinements, while also conducting 3 cycles of pilot testing of these potential refinements. Based on the preparation and final synthesis of the intervention refinements, in the second phase the investigators will conduct an RCT to test the efficacy of YORS, by randomizing N=120 young adults ages 18-26 seeking treatment for OUD with XR-NTX at Mountain Manor Treatment Center (MMTC), to either the refined YORS intervention or treatment as usual (TAU) for a 6-month course of treatment with XR-NTX.
The primary outcome will be number of XR-NTX doses received. Secondary outcomes will include opioid relapse, days of opioid use, time to first opioid relapse, HIV risk behaviors, criminal behaviors, psychiatric symptoms, and family member distress and self-efficacy. It is hypothesized that participants in the YORS condition will receive significantly more XR-NTX doses and will demonstrate less severe opioid use and associated behaviors compared to those in the TAU group. The assertive YORS intervention has the potential to improve the real-world effectiveness and public health impact of medication for OUD in this very high-risk, vulnerable population. If the refined YORS intervention is found to be efficacious, it would set the stage for future work including: an economic analysis, a larger multi-site study, longer intervention duration, study of extended release buprenorphine, and study of step-down to less intensive interventions.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kevin Wenzel, PhD
- Phone Number: 410-233-1400
- Email: kwenzel@mountainmanor.org
Study Contact Backup
- Name: Marc Fishman, MD
- Phone Number: 410-233-1400
- Email: mjfishman@comcast.net
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21229
- Recruiting
- Mountain Manor Treatment Center
-
Contact:
- Kevin Wenzel, PhD
- Phone Number: 261 410-233-1400
- Email: kwenzel@mountainmanor.org
-
Contact:
- Marc Fishman, MD
- Phone Number: 130 4102331400
- Email: mfishman@marylandtreatment.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18-28
- OUD diagnosis
- Willing (intending) to receive treatment with XR-NTX or XR-BUP under the care of a MTC physician/nurse practitioner
- Willingness to designate family member (or other suitable treatment significant other) for treatment involvement (i.e., a treatment significant other; TSO)
Exclusion Criteria:
- Psychiatric or medical instability (e.g., suicidality, psychosis, Sickle Cell disease with frequent crises) that would preclude participation in the trial
- Living situation (location greater than 75 miles from the center, homelessness) that would preclude participation in the trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Youth Opioid Recovery Support (YORS)
The Youth Opioid Recovery Support (YORS) model is an innovative wrap-around approach that attempts to address barriers to treatment engagement in this vulnerable young adult population, especially difficulties with medication adherence. Its components include: (1) Home delivery of extended release naltrexone (XR-NTX) for OUD; (2) Engagement of families in collaborative treatment planning and monitoring focusing on medication adherence; (3) Assertive outreach from the treatment team including actively tracking and communicating with youth and families by text messaging and social media to promote engagement and adherence; and (4) Contingency management to provide incentives for medication adherence. The specific components of YORS will be refined and adapted based on feedback from interviews and focus groups with various stakeholders. However, the basic framework outlined above is expected to persists. |
The Youth Opioid Recovery Support (YORS) model is an innovative wrap-around approach that attempts to address barriers to treatment engagement in this vulnerable young adult population, especially difficulties with medication adherence.
Its components include: (1) Home delivery of extended release naltrexone (XR-NTX) for OUD; (2) Engagement of families in collaborative treatment planning and monitoring focusing on medication adherence; (3) Assertive outreach from the treatment team including actively tracking and communicating with youth and families by text messaging and social media to promote engagement and adherence; and (4) Contingency management to provide incentives for medication adherence.
|
No Intervention: Treatment As Usual
TAU will contain patients who will be receiving treatment for opioid use disorder through their usual venues without the family engagement, assertive outreach, contingency management, and home delivery of medication.
This often includes a referral and warm hand off to intensive outpatient SUD services and/or mental health care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of MOUD injections received (XR-NTX or XR-BUP)
Time Frame: Treatment week 0 to 26 weeks
|
Total number of injections received within 26 weeks
|
Treatment week 0 to 26 weeks
|
Rate of opioid relapse during the study period
Time Frame: Time Frame: Data measured every 2 weeks for the duration of the 26-week study period
|
Relapse = 10 days of use within a 28 day period.
Days of opioid use will be assessed through urine toxicology and self report methods.
|
Time Frame: Data measured every 2 weeks for the duration of the 26-week study period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marc Fishman, MD, Maryland Treatment Centers
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R61AT010614 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Adherence
-
NYU Langone HealthRobert Wood Johnson Foundation; New York City Health and Hospitals CorporationCompletedMedication Adherence | Medication ErrorsUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingMedication Adherence | Medication ComplianceUnited States
-
Vanderbilt University Medical CenterCompletedAdherence, Medication | Nonadherence, MedicationUnited States
-
Universidad Autonoma de Baja CaliforniaCompletedMedication Adherence | Medication ComplianceMexico
-
Universiti Putra MalaysiaCompletedMedication Adherence | Adherence, TreatmentPakistan
-
University Hospital, Basel, SwitzerlandUniversity of BaselCompletedPolymedication-Check With Insight in Patients' Medication Organisation and Comprehension of GenericsMedication Adherence | Medication Therapy ManagementSwitzerland
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Sir Halley Stewart TrustCompletedMedication Adherence | Medication Compliance | Attitude | CaregiversUnited Kingdom
-
National Healthcare Group, SingaporeCompletedMedication Adherence | Medication Administered in Error
-
Cliniques universitaires Saint-Luc- Université...RecruitingAdherence, MedicationBelgium
-
Northwell HealthNational Institute on Aging (NIA)RecruitingMedication AdherenceUnited States
Clinical Trials on Youth Opioid Recovery Support (YORS)
-
Potomac Health FoundationsCompletedOpioid-Related DisordersUnited States
-
University of Maryland, BaltimoreCompleted
-
University of California, IrvineUniversity of Maryland, Baltimore CountyNot yet recruitingSuicide | Psychosis | Health Care Utilization | Family Members
-
University of PennsylvaniaCompletedCocaine DependenceUnited States
-
University of RochesterCompletedSubstance Use Disorders | Infective Endocarditis | IV Drug UsageUnited States
-
West Virginia UniversityRecruitingSubstance Abuse DisorderUnited States
-
Q2i, LLCNational Institute on Drug Abuse (NIDA); University of Massachusetts, WorcesterCompletedContingency Management | Opioid-use Disorder | Medication for Opioid-use DisorderUnited States
-
UConn HealthUniversity of Texas at Austin; Oregon Social Learning CenterEnrolling by invitationSubstance Use DisordersUnited States
-
VA Office of Research and DevelopmentRecruitingPsychotic Disorders | Suicidal Ideation | Suicide, Attempted | Bipolar DisordersUnited States
-
US Department of Veterans AffairsCompleted